ArticleWorld journal of clinical oncology2024

Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma.

Shi-Qiong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.